INCATE: a partnership to boost the antibiotic pipeline

INCATE, the INCubator for Antibacterial Therapies in Europe, aims to boost the antibiotic pipeline by accelerating the translation of academic innovation into industrial R&D projects to tackle antimicrobial resistance. Founded in 2021 as a partnership of research institutions and pharma companie...

Full description

Saved in:

Bibliographic Details
Published in:	Nature reviews. Drug discovery Vol. 21; no. 9; pp. 621 - 622
Main Authors:	Alt, Silke, Haggstrom, Douglas, Kessmann, Helmut, Kloss, Florian, Schneider, Christian Elias, Jäger, Timo, Schwede, Torsten, Brakhage, Axel, Dehio, Christoph
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 01-09-2022 Nature Publishing Group
Subjects:	Biomedicine Biotechnology Cancer Research Comment Medicinal Chemistry Molecular Medicine Pharmacology/Toxicology
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	INCATE, the INCubator for Antibacterial Therapies in Europe, aims to boost the antibiotic pipeline by accelerating the translation of academic innovation into industrial R&D projects to tackle antimicrobial resistance. Founded in 2021 as a partnership of research institutions and pharma companies, INCATE provides advice, community and non-dilutive funding to start-up companies. INCATE, the INCubator for Antibacterial Therapies in Europe, aims to boost the antibiotic pipeline by accelerating the translation of academic innovation into industrial R&D projects to tackle antimicrobial resistance. Founded in 2021 as a partnership of research institutions and pharma companies, INCATE provides advice, community and non-dilutive funding to start-up companies.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	1474-1776 1474-1784
DOI:	10.1038/d41573-022-00138-7